全文获取类型
收费全文 | 32574篇 |
免费 | 1413篇 |
国内免费 | 157篇 |
专业分类
耳鼻咽喉 | 260篇 |
儿科学 | 551篇 |
妇产科学 | 316篇 |
基础医学 | 3862篇 |
口腔科学 | 881篇 |
临床医学 | 1928篇 |
内科学 | 7810篇 |
皮肤病学 | 472篇 |
神经病学 | 2646篇 |
特种医学 | 1501篇 |
外科学 | 5732篇 |
综合类 | 180篇 |
一般理论 | 1篇 |
预防医学 | 1092篇 |
眼科学 | 943篇 |
药学 | 2452篇 |
中国医学 | 96篇 |
肿瘤学 | 3421篇 |
出版年
2023年 | 117篇 |
2022年 | 263篇 |
2021年 | 469篇 |
2020年 | 289篇 |
2019年 | 375篇 |
2018年 | 478篇 |
2017年 | 373篇 |
2016年 | 500篇 |
2015年 | 508篇 |
2014年 | 651篇 |
2013年 | 940篇 |
2012年 | 1522篇 |
2011年 | 1705篇 |
2010年 | 938篇 |
2009年 | 805篇 |
2008年 | 1561篇 |
2007年 | 1790篇 |
2006年 | 1848篇 |
2005年 | 1842篇 |
2004年 | 1864篇 |
2003年 | 1694篇 |
2002年 | 1757篇 |
2001年 | 1031篇 |
2000年 | 1016篇 |
1999年 | 921篇 |
1998年 | 512篇 |
1997年 | 419篇 |
1996年 | 399篇 |
1995年 | 300篇 |
1994年 | 310篇 |
1993年 | 258篇 |
1992年 | 623篇 |
1991年 | 586篇 |
1990年 | 562篇 |
1989年 | 537篇 |
1988年 | 475篇 |
1987年 | 464篇 |
1986年 | 459篇 |
1985年 | 443篇 |
1984年 | 294篇 |
1983年 | 230篇 |
1982年 | 148篇 |
1981年 | 131篇 |
1980年 | 120篇 |
1979年 | 210篇 |
1978年 | 147篇 |
1977年 | 131篇 |
1975年 | 109篇 |
1973年 | 109篇 |
1970年 | 115篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
971.
972.
Toru Kitazawa MD Hiroaki Seino MD Hiroshi Ohashi MD Takeshi Inazawa MD Masahiro Inoue MD Masumi Ai MD Midori Fujishiro MD Hisamoto Kuroda MD Masayo Yamada MD Motonobu Anai MD Hisamitsu Ishihara MD 《Diabetes, obesity & metabolism》2020,22(9):1659-1663
Metformin plus a dipeptidyl peptidase-4 inhibitor (DPP-4i) is the most common therapy for Japanese patients with type 2 diabetes. This 24-week, multicentre, open-label, parallel-group trial randomized patients on dual therapy to add-on tofogliflozin (20 mg/day, n = 33) or glimepiride (0.5 mg/day, n = 31). The primary outcome was change in body fat percentage. The secondary outcomes included changes in HbA1c, fat mass, fat-free mass, liver function variables and uric acid. Tofogliflozin and glimepiride reduced HbA1c to a similar extent. Body fat percentage did not change from baseline in either group. Fat mass was reduced by tofogliflozin but was increased by glimepiride (by −2.0 ± 1.7 kg and +1.6 ± 1.6 kg, P = .002). Fat-free mass was also reduced by tofogliflozin and increased by glimepiride (by −1.3 ± 1.3 kg and +0.9 ± 2.0 kg, P < .001). Alanine aminotransferase and uric acid levels were reduced by tofogliflozin (P = .006 and P < .001, respectively). These data provide novel information useful for selecting the third oral agent for patients whose diabetes is inadequately controlled with metformin plus DPP-4i dual therapy. 相似文献
973.
Michihiro Satoh Miki Hosaka Kei Asayama Masahiro Kikuya Ryusuke Inoue Hirohito Metoki 《Clinical and experimental hypertension (New York, N.Y. : 1993)》2014,36(2):108-114
Based on ambulatory blood pressure (BP) monitoring, the aldosterone-to-renin ratio (ARR) has been reported to be associated with a diminished nocturnal decline in BP, generally referred to as a “non-dipping” pattern. The objective of this cross-sectional study was to investigate the association between ARR and the non-dipping pattern based on home BP measurements. This study included 177 participants ≥55 years from the general population of Ohasama (mean age: 67.2 years; 74.6% women); no patient was receiving antihypertensive treatment. The median plasma renin activity (PRA), plasma aldosterone concentration (PAC) and ARR were 0.8?ng/mL/h, 8.1?ng/dL and 9.7?ng/dL per ng/mL/h, respectively. Each 1 SD increase in log-transformed (ln) ARR was significantly associated with the prevalence of the non-dipping pattern after adjustments for possible confounding factors including home morning systolic BP (odds ratio, 1.45; p?=?0.049). However, no significant associations of PRA or PAC with the non-dipping pattern were observed (p?≥?0.2). When participants were divided into four groups according to median levels of home morning and night-time systolic BPs, the group with a higher home morning systolic BP (≥128.4?mmHg) with a higher home night-time systolic BP (≥114.4?mmHg) had the greatest ARR levels (ANCOVA p?=?0.01). These results support the hypothesis that relative aldosterone excess may be related to a non-dipping pattern in a general population and suggest that a non-dipping pattern can be accurately observed by home BP measurements. 相似文献
974.
975.
976.
977.
Narabayashi K Murano M Egashira Y Noda S Kawakami K Ishida K Kuramoto T Abe Y Inoue T Murano N Tokioka S Takii M Umegaki E Higuchi K 《Digestion》2012,85(2):136-140
Collagenous colitis (CC) is a well-known cause of chronic non-bloody diarrhea, especially in elderly women. CC is characterized histopathologically by an increase in the thickness of the subepithelial collagen layer to at least 10 μm, epithelial damage, and chronic inflammation of the lamina propria. Generally, the colonic mucosa in CC is macroscopically normal, although minor, non-specific abnormalities may be found. Due to the recent advancement of endoscopic and diagnostic technologies, however, microscopic mucosal abnormalities and specific longitudinal linear lacerations of the mucosa characteristic of CC have been identified. The association of CC with non-steroidal anti-inflammatory drugs and proton pump inhibitors has also been reported. Since definitive diagnosis of CC has to rely on pathologically documented collagen bands and mononuclear infiltration, the efficiency and precision of colonic biopsy need to be improved. Of the 29 CC patients that we have encountered at our institution, it was in 15 of 29 cases that the endoscopic finding that we performed a biopsy on was apparent. Our comparison of the endoscopic and histopathological findings of CC in the 15 patients showed that the mucosa frequently appeared coarse and nodular on the surface of the mucosa, which was also significantly thicker in collagen bands, demonstrating a strong correlation between collagen band formation and CC. Also, the coarse and nodular surface of the mucosa was most frequently seen affecting the proximal colon. The results suggest that endoscopic observation and biopsy of the proximal colon, where a coarse and nodular surface of the mucosa is often found, may be useful for confirmation of the diagnosis in patients with suspected CC. 相似文献
978.
H Okada M Takemoto Y Kawahara J Nasu R Takenaka S Kawano M Inoue K Ichimura T Tanaka K Shinagawa T Yoshino K Yamamoto 《Digestion》2012,86(3):179-186
Background/Aims: Few studies exist on the efficacy and long-term outcome of radiation therapy (RT) for gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Methods: Twenty-two patients with stage I or stage II(1) disease were prospectively evaluated, including 14 patients without Helicobacter pylori(H. pylori) infection and 8 patients with persistent lymphoma after H. pylori eradication. RT dose was 30 Gy in daily fractions of 1.5 Gy. All patients underwent endoscopic and histological follow-up regularly. Results: The study included 22 patients with a mean age of 63 years. The t(11;18)(q21;q21) translocation occurred in 8 of the 22 cases. All patients showed complete remission without any serious toxicity. At a median follow-up evaluation 74 months (range 27-159) after completion of RT, the overall and relapse-free survival rates after 5 years were 91 and 84%, respectively. Although no patient showed local recurrence of lymphoma, distant recurrence was detected in 3 patients, all of whom were H. pylori negative; MALT lymphoma relapsed in two patients with the t(11;18)(q21;q21) translocation, and diffuse large-cell lymphoma developed in one patient without the translocation. Conclusion: RT provides excellent local control of the gastric MALT lymphoma. However, continuous follow-up is mandatory as relapse may occur in other sites. 相似文献
979.
980.